» Articles » PMID: 32419901

Alcohol and Multiple Sclerosis: an Immune System-based Review

Overview
Date 2020 May 19
PMID 32419901
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis is a chronic inflammatory disease of the central nervous system (CNS). Although the exact etiology of multiple sclerosis is unknown, researchers suggest that genetic, environmental, and microbial factors play a central role in causing multiple sclerosis. Pathology of multiple sclerosis is based on inflammation as T cells enter the brain via disruptions in the blood-brain barrier, recognizing myelin as foreign antigen; and as a result, the T cells attack myelin and start the inflammatory processes, enhancing inflammatory cytokines and antibodies. Since previous studies show ethanol can suppress the immune system such as innate, humoral, and cellular immunity and increases the production of anti-inflammatory cytokines, we hypothesized maybe ethanol also have ameliorating effects on multiple sclerosis symptoms. Although alcohol induces apoptosis in oligodendrocytes and neurons, causing demyelination and affects CNS directly, in this study we will investigate ethanol's effects on some aspects of the immune system in multiple sclerosis.

Citing Articles

Association of Beverage Consumption with Cardio-metabolic Risk Factors and Alanine Transaminase Levels in Children and Adolescents: The CASPIAN-V Study.

Khademian M, Shahsavari A, Qorbani M, Motlagh M, Heshmat R, Khozani E Adv Biomed Res. 2024; 13:65.

PMID: 39434948 PMC: 11493221. DOI: 10.4103/abr.abr_130_22.


The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank.

Mazzucca C, Scotti L, Comi C, Vecchio D, Chiocchetti A, Cappellano G Nutrients. 2024; 16(11).

PMID: 38892680 PMC: 11174354. DOI: 10.3390/nu16111746.


Effect of Silybum Marianum on Reduction of Chemotherapy-Induced Peripheral Neurotoxicity with Cisplatin.

Gholami A, Ansari H, Dadkhah A Adv Biomed Res. 2024; 13:21.

PMID: 38808323 PMC: 11132193. DOI: 10.4103/abr.abr_365_21.


The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review.

Nociti V, Romozzi M J Pers Med. 2023; 13(11).

PMID: 38003839 PMC: 10672087. DOI: 10.3390/jpm13111524.


Prevalence and sociodemographic correlates of antinuclear antibody testing by indirect immunofluorescence or solid-phase assays in a Spanish population: the Camargo Cohort.

Irure-Ventura J, Martinez-Revuelta D, Lopez-Hoyos M, Martin-Millan M, Nan D, Pariente E Immunol Res. 2023; 72(2):260-270.

PMID: 37924421 PMC: 11031476. DOI: 10.1007/s12026-023-09430-z.


References
1.
Willing A, Leach O, Ufer F, Attfield K, Steinbach K, Kursawe N . CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol. 2014; 44(10):3119-28. DOI: 10.1002/eji.201344160. View

2.
Heinz R, Waltenbaugh C . Ethanol consumption modifies dendritic cell antigen presentation in mice. Alcohol Clin Exp Res. 2007; 31(10):1759-71. DOI: 10.1111/j.1530-0277.2007.00479.x. View

3.
Mirshafiey A, Mohsenzadegan M . TGF-beta as a promising option in the treatment of multiple sclerosis. Neuropharmacology. 2009; 56(6-7):929-36. DOI: 10.1016/j.neuropharm.2009.02.007. View

4.
Steeland S, Van Ryckeghem S, Van Imschoot G, De Rycke R, Toussaint W, Vanhoutte L . TNFR1 inhibition with a Nanobody protects against EAE development in mice. Sci Rep. 2017; 7(1):13646. PMC: 5651799. DOI: 10.1038/s41598-017-13984-y. View

5.
Bonora M, De Marchi E, Patergnani S, Suski J, Celsi F, Bononi A . Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process. Cell Death Differ. 2014; 21(8):1198-208. PMC: 4085526. DOI: 10.1038/cdd.2014.35. View